Empowering Consumers Hurt by Big Businesses

Local (415) 319-8833
Toll Free (855) 534-0061

Recent Posts in Type 2 Diabetes Category

  • SGLT2 Inhibitors Linked to Fatal Ketoacidosis Cases

    Between July 8, 2016 and August 17, 2016, the FDA approved important safety updates to the labels of all SGLT2 inhibitors. These drugs are used to treat Type 2 diabetes by causing the kidneys to remove excess glucose from the body through the urine. Taken as a whole, the new safety labeling changes warn that there have been fatal cases of ketoacidosis in patients taking any and all of the drugs ...
    Continue Reading
Page 1 of 1